ClinicalTrials.govpublic full text
MD1003-AMN MD1003 in Adrenomyeloneuropathy
adrenomyeloneuropathy, adrenoleukodystrophy, amn, md1003, ald, biotin, 2mwt, two-minute walk test, tw25, timed 25-foot walk, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 854854
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.